Showing promise in the landscape of weight management management, retatrutide represents a different approach. Different from many current medications, retatrutide works as a twin agonist, concurrently affecting both GLP-like peptide-1 (GLP-1) and glucose-dependent insulinotropic hormone (GIP) sensors. The concurrent engagement promotes various hel